SE7410332L - - Google Patents

Info

Publication number
SE7410332L
SE7410332L SE7410332A SE7410332A SE7410332L SE 7410332 L SE7410332 L SE 7410332L SE 7410332 A SE7410332 A SE 7410332A SE 7410332 A SE7410332 A SE 7410332A SE 7410332 L SE7410332 L SE 7410332L
Authority
SE
Sweden
Prior art keywords
dansyl
thrombosis
amides
suppression
inhibition
Prior art date
Application number
SE7410332A
Other languages
English (en)
Other versions
SE420919B (sv
Inventor
S Okamoto
R Kikumoto
Y Tamao
S Tonomura
K Ohkubo
Original Assignee
Mitsubishi Chem Ind
Okamoto Shosuke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP9069973A external-priority patent/JPS5521742B2/ja
Priority claimed from JP11603573A external-priority patent/JPS5521743B2/ja
Priority claimed from JP11729273A external-priority patent/JPS5521744B2/ja
Priority claimed from JP13750173A external-priority patent/JPS5521745B2/ja
Priority claimed from JP3114174A external-priority patent/JPS5542073B2/ja
Priority claimed from JP3326074A external-priority patent/JPS5521746B2/ja
Application filed by Mitsubishi Chem Ind, Okamoto Shosuke filed Critical Mitsubishi Chem Ind
Publication of SE7410332L publication Critical patent/SE7410332L/xx
Publication of SE420919B publication Critical patent/SE420919B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/16—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with acylated ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/08—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms with acylated ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/12—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
SE7410332A 1973-08-13 1974-08-13 Forfarande for framstellning av n?722-dansyl-l-argininderivat och farmaceutiskt godtagbara syradditionssalter derav SE420919B (sv)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP9069973A JPS5521742B2 (en, 2012) 1973-08-13 1973-08-13
JP11603573A JPS5521743B2 (en, 2012) 1973-10-16 1973-10-16
JP11729273A JPS5521744B2 (en, 2012) 1973-10-18 1973-10-18
JP13750173A JPS5521745B2 (en, 2012) 1973-12-10 1973-12-10
JP3114174A JPS5542073B2 (en, 2012) 1974-03-19 1974-03-19
JP3326074A JPS5521746B2 (en, 2012) 1974-03-25 1974-03-25

Publications (2)

Publication Number Publication Date
SE7410332L true SE7410332L (en, 2012) 1975-02-14
SE420919B SE420919B (sv) 1981-11-09

Family

ID=27549573

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7410332A SE420919B (sv) 1973-08-13 1974-08-13 Forfarande for framstellning av n?722-dansyl-l-argininderivat och farmaceutiskt godtagbara syradditionssalter derav

Country Status (2)

Country Link
US (1) US4227006A (en, 2012)
SE (1) SE420919B (en, 2012)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL165652C (nl) * 1973-08-13 1981-05-15 Mitsubishi Chem Ind Werkwijze ter bereiding van een preparaat met anti- trombosewerking en/of diagnosticum voor trombine in bloed op basis van l-argininederivaten, het gevormde preparaat, het gevormde diagnosticum en werkwijze ter bereiding van l-argininederivaten.
JPS6061557A (ja) * 1983-09-14 1985-04-09 Nitto Boseki Co Ltd アルギニル−ｐ−ニトロアニリド化合物の製造方法
EP0183271B1 (en) * 1984-11-30 1990-05-16 Shosuke Okamoto Lysin derivative and proteinase inhibitor
TW201303B (en, 2012) * 1990-07-05 1993-03-01 Hoffmann La Roche
TW223629B (en, 2012) * 1992-03-06 1994-05-11 Hoffmann La Roche
TW394760B (en) * 1993-09-07 2000-06-21 Hoffmann La Roche Novel Carboxamides, process for their preparation and pharmaceutical composition containing the same
KR20150108430A (ko) * 2005-09-01 2015-09-25 백스터 인터내셔널 인코포레이티드 가용화제로서의 산을 포함하는 아가트로반 제제
US7915290B2 (en) * 2008-02-29 2011-03-29 Baxter International Inc. Argatroban formulations and methods for making and using same
US20090221637A1 (en) * 2008-02-29 2009-09-03 Baxter International Inc. Solid-state salt argatroban formulations and methods for producing and using the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3622615A (en) * 1968-11-06 1971-11-23 Parke Davis & Co N{11 -(p-tolylsulfonyl)-L-arginine esters

Also Published As

Publication number Publication date
SE420919B (sv) 1981-11-09
US4227006A (en) 1980-10-07

Similar Documents

Publication Publication Date Title
HU173557B (hu) Sposob poluchenija 3-amino-indazol-karbonovojj kisloty i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami
SE7413349L (en, 2012)
NO142670C (no) Benzylpenicillinester for anvendelse som utgangsmateriale ved fremstilling av en terapeutisk virksom ester av alfa-aminobenzylpenicilliner
SE7410332L (en, 2012)
AT307384B (de) Verfahren zur Herstellung des neuen 1-Isopropylamino-3-(p-methoxyäthoxyäthoxyphenoxy)-propanols-2 und dessen pharmazeutisch annehmbarer Säureadditionssalze
ES415000A1 (es) Procedimiento para la preparacion de difenil-alea-noilami- nopiridinas.
ES385523A1 (es) Procedimiento para la preparacion de compuestos farmacolo- gicamente activos de esteres de acido antranilico.
YU36738B (en) Process for obtaining pharmaceutically active alcaloid esters of the eburnamine type
IL35875A0 (en) New pharmaceutical compositions for the treatment of microbial infections containing a glutamic acid derivative
EG10710A (en) Process for the manufacture of new derivatives of 7-aminocephalosporanic acid having a curative action & can be used as a preservative for food and as antiseptics
IL42438A0 (en) The preparation of benzimidazol-2-yl-carbamic acid alkyl esters
IL48394A (en) Trisubstituted benzophenone derivatives process for preparring them and pharmaceutical compositions
PT64980B (en) Process for preparing carboxylic acid amides with hypolipaemic effect application of the same for preparing pharmaceutical compositions with hypolipaemic effect and application of said pharmaceutical compositions for the treatment of hyperlipaemia
PH12292A (en) 7b-(d-5-amino-5-carboxyvaleramido)-7-methoxy-3-cephem 4-carboxylic acids and pharmacologically acceptable salts thereof and pharmaceutical compositions containing same
FI47882C (fi) Menetelmä kolesterolia alentavana aineena käytettävien, rikkiä sisältä vien N-substituoitujen rasvahappoamidien valmistamiseksi
ZA704782B (en) Pharmacologically active esters of n-(3-trifluoromethylphenyl)-anthranilic acid and process for preparing them
IL35249A0 (en) The use of 2-chloroethane-phosphonic and thiono-phosphonic acid amino compounds as agents for the regulation of plant growth
IL46726A0 (en) Esters of aminoalkanoic acids
IL43396A (en) Process for the preparation of 2-benzimidazole-carbamic acid alkyl and benzyl esters
IL39246A0 (en) The preparation of n-substituted n-chloromethyl-carbamic acid esters and thiolesters
EG11264A (en) Process for the preparation of basic esters and salts thereof
CA989309A (en) Pharmaceutical composition for the treatment of acne containing fatty acid amides
GB1533647A (en) Aryloxyalkylaminobenzoic acids and esters as hypolipemic compounds
IL32616A (en) Derivatives of 5-thiazole carboxylic acid and process for the preparation thereof
EG10517A (en) Method of inhibiting the hydrolysis of acetylsalicylic acid and propoxyphene hydrochloride

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7410332-6

Effective date: 19940910

Format of ref document f/p: F